TAP Blocks vs. IV Lidocaine for Kidney Transplants

• Status: Unknown status
• Trial end date: 2021-09-01
• Target enrollment: 0
• Participant gender: All

Summary

This study will compare continuous intravenous lidocaine against single-injection transversus abdominis plane (TAP) block as a modality for postoperative analgesia in kidney transplant surgery.

• Phase: Phase 2/Phase 3
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Benaroya Research Institute
• Treatments: Lidocaine

Criteria

Inclusion Criteria:

• Kidney transplant recipient

• >18 years old

• Consent to participate

Exclusion Criteria:

• <18 years old

• Refusal to participate

• Chronic opioid use

• Seizure disorder

• Allergy to local anesthestics

• Severe hepatic disease